
CN Healthy Food Tech Group Corp.
80
Recent developments include the appointment of a new CFO at Iron Horse Acquisitions Corp., the parent company involved in the business combination with CN Healthy Food Tech Group Corp.
- Iron Horse Acquisitions Corp. appointed a new Chief Financial Officer as reported on October 28, 2024.[N1]
CN Healthy Food Tech Group Corp. is a health and wellness food distributor focusing on natural, grain-based products that integrate traditional Chinese medicine with modern technology. The company operates primarily in China through wholly owned subsidiaries and commenced operations in May 2024. Its business model includes two main revenue streams: wholesale distribution of health food products to distributors and live-stream sales of digital coupons redeemable at third-party merchants. The company acts as principal in these transactions, bearing inventory risk and controlling pricing. Marketing efforts utilize a mix of digital and offline channels to attract and retain distributors and customers. The company relies on OEM suppliers for product manufacturing and faces risks related to supplier disruptions and inventory management. Financially, the company reported $5.8 million in revenue and a net loss of $309,000 for Q1 2026, with cash and equivalents of $29.7 million and a current ratio of 1.65. The company is currently subject to a Nasdaq trading halt pending regulatory review by the CSRC, which impacts stock liquidity and capital raising ability. It also faces administrative fines from the CSRC and has defaulted on promissory notes that carry conversion rights potentially dilutive to shareholders.
Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. CN Healthy Food Tech Group Corp. operates in the health and wellness food industry, distributing natural, grain-based health foods primarily in China. The company generates revenue from wholesale distribution and live-stream sales of digital coupons. As of March 31, 2026, it reported $5.8 million in revenue and a net loss of approximately $309,000. The company holds $29.7 million in cash and equivalents with a current ratio of 1.65. The Nasdaq trading halt since October 2025 due to regulatory review materially affects stock liquidity and capital access. The company faces regulatory fines from the CSRC and has defaulted promissory notes with potential dilution risks. Operations depend on OEM suppliers and are subject to PRC regulatory and currency transfer restrictions.
The company’s integration of traditional Chinese medicine with modern health food products aligns with increasing consumer interest in natural wellness solutions. Its dual revenue streams from wholesale distribution and live-stream sales offer diversified growth avenues. The company’s marketing strategies leveraging digital and offline channels aim to expand its customer base and distributor network. Its intellectual property portfolio including trademarks and patents supports product uniqueness. The company’s cash position and operating cash flows provide liquidity to support ongoing operations and strategic initiatives.
The company faces significant risks including a prolonged Nasdaq trading halt due to regulatory review by the CSRC, which restricts stock liquidity and access to capital markets. Administrative fines imposed by the CSRC and related regulatory scrutiny may impact reputation and operational licenses. Defaulted promissory notes with conversion rights pose dilution risks to shareholders. Dependence on OEM suppliers exposes the company to supply chain disruptions. Regulatory and currency transfer restrictions in China may limit cash flow flexibility and dividend distributions. These factors collectively create uncertainty around the company’s financial stability and growth prospects.
The company’s moat is based on its niche focus on health and wellness food products that blend traditional Chinese medicine with modern nutritional science, catering to a growing demand for natural and preventative health solutions in China. Its distribution network and live-stream sales platform provide multiple channels to reach customers. The company holds multiple trademarks and patents related to its products and packaging, supporting product differentiation. However, reliance on OEM suppliers and regulatory risks in China present challenges to sustaining competitive advantages.
• Nasdaq Trading Halt: The company’s common stock and warrants have been halted from trading on Nasdaq since October 1, 2025, due to pending regulatory review by the China Securities Regulatory Commission (CSRC). This materially impairs stock liquidity, may affect capital raising, employee retention, and could lead to delisting.
• CSRC Administrative Penalties: The CSRC imposed administrative fines totaling RMB 4.5 million on the company and its CEO related to the overseas listing process. This may adversely affect the company’s reputation, regulatory status, and ability to conduct business in China.
• Defaulted Promissory Notes and Dilution Risk: Three promissory notes totaling approximately $3.47 million principal plus accrued default interest remain in default as of March 31, 2026. Conversion provisions could lead to substantial dilution if enforced. Discussions with note holders are ongoing but uncertain.
• Supply Chain Dependence: The company relies entirely on OEM suppliers for raw materials and manufacturing finished products, exposing it to risks of production delays, shortages, and quality issues.
• Regulatory and Currency Transfer Restrictions: Operations are subject to PRC laws and regulations that restrict cash transfers and dividend distributions from PRC subsidiaries, potentially limiting financial flexibility.
Business trends: The company focuses on expanding its health and wellness food distribution and live-stream sales in China, leveraging digital marketing and product innovation.
Execution milestones: Completion of business combination with Iron Horse Acquisitions Corp., ongoing regulatory review by CSRC, and management changes including new CFO appointment.
Key risks: Prolonged Nasdaq trading halt, regulatory fines and scrutiny by CSRC, defaulted promissory notes with dilution potential, supply chain dependencies, and PRC regulatory restrictions on cash flow.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- CN Healthy Food Tech Group Corp. operates in the health and wellness food industry, focusing on distributing natural, grain-based health foods that support preventative health and wellness, blending modern technology with traditional Chinese medicine.
- The company commenced operations in May 2024 and offers products including Shangshan Suyang Porridge, plant-based essential oils, collagen peptide prebiotics, natto compound gummy supplements, and similar health products.
- Revenue is generated primarily from two segments: wholesale distribution of inventories to distributors and live-stream sales of digital coupons redeemable at third-party merchants.
- The company acts as principal in sales transactions, bearing inventory risk and setting prices, recognizing revenue at the point of transfer of control to customers.
- Marketing efforts include digital and offline channels such as social media, keyword search campaigns, affiliate programs, influencer partnerships, and traditional advertising.
- The company does not have in-house production and relies entirely on OEM suppliers for raw materials and finished products, exposing it to supplier risks.
- As of March 31, 2026, the company reported cash and cash equivalents of approximately $29.7 million and current assets of about $31.4 million, with current liabilities of approximately $19.0 million, resulting in a current ratio of 1.65 and a cash ratio of 1.56.
- For the quarter ended March 31, 2026, revenue was approximately $5.8 million, with a net loss of about $309,000 and basic and diluted EPS of -$0.0059 per share.
- The company faces a Nasdaq trading halt since October 1, 2025, due to pending regulatory review by the China Securities Regulatory Commission (CSRC), which materially impairs stock liquidity and may affect capital raising and employee retention.
- The CSRC imposed administrative fines totaling RMB 4.5 million on the company and its CEO related to the overseas listing process, with potential reputational and regulatory impacts.
- Three promissory notes totaling approximately $3.47 million principal plus accrued default interest remain in default as of March 31, 2026, with conversion provisions that could cause dilution if enforced.
- The company is engaged in discussions with note holders to address defaults but faces risks if agreements are not reached, including potential adverse financial impacts.
- The company’s operations are primarily conducted in China, subject to PRC laws and regulations, including restrictions on cash transfers and dividend distributions from PRC subsidiaries.
- The company’s liquidity is supported by cash and operating cash flows but may require additional capital resources depending on business conditions and segment revenue mix.
- The company’s marketing expenses vary period to period and include advertising and promotional campaigns to attract and retain distributors and customers.
- The company’s financial disclosures are summarized from SEC filings and provided for informational purposes only, without financial advice.
- Recent news includes the appointment of a new CFO at Iron Horse Acquisitions Corp., the parent company involved in the business combination with CN Healthy Food Tech Group Corp.[N1]
Generated 2026-06-12
- S1 | 2026-06-12 | 10-K/A
- S2 | 2026-05-13 | 10-Q
- N1 | 2024-10-28 | www.nasdaq.com | Iron Horse Acquisitions Corp. Appoints New CFO | https://www.nasdaq.com/articles/iron-horse-acquisitions-corp-appoints-new-cfo
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


